These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 23343825)
1. Acute promyelocytic leukemia-associated thrombosis. Chang H; Kuo MC; Shih LY; Wu JH; Lin TL; Dunn P; Tang TC; Hung YS; Wang PN Acta Haematol; 2013; 130(1):1-6. PubMed ID: 23343825 [TBL] [Abstract][Full Text] [Related]
2. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia. Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178 [TBL] [Abstract][Full Text] [Related]
3. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation]. Yang H; Zhu CY; Wang QS; Niu JH; Zhang Q; Zhu HY; Yao ZL; Xu YY; Jing Y; Yu L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):315-22. PubMed ID: 24762998 [TBL] [Abstract][Full Text] [Related]
4. Open issues on bleeding and thrombosis in acute promyelocytic leukemia. Sanz MA; Montesinos P Thromb Res; 2010 Apr; 125 Suppl 2():S51-4. PubMed ID: 20434005 [TBL] [Abstract][Full Text] [Related]
5. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients. Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524 [TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia. Ventura GJ; Hester JP; Dixon DO; Khorana S; Keating MJ Hematol Pathol; 1989; 3(1):23-8. PubMed ID: 2745357 [TBL] [Abstract][Full Text] [Related]
7. Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: a single-institution experience. Grisariu S; Spectre G; Kalish Y; Gatt ME Eur J Haematol; 2013 May; 90(5):397-403. PubMed ID: 23414485 [TBL] [Abstract][Full Text] [Related]
9. Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes and Healthcare Burden in US Hospitals. Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S Turk J Haematol; 2024 Mar; 41(1):1-8. PubMed ID: 38374587 [TBL] [Abstract][Full Text] [Related]
10. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956 [TBL] [Abstract][Full Text] [Related]
11. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment. Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375 [TBL] [Abstract][Full Text] [Related]
12. Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy. Dixit A; Chatterjee T; Mishra P; Kannan M; Choudhry DR; Mahapatra M; Choudhry VP; Saxena R Clin Appl Thromb Hemost; 2007 Jul; 13(3):292-8. PubMed ID: 17636191 [TBL] [Abstract][Full Text] [Related]
13. Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia. Lee HJ; Kim DH; Lee S; Koh MS; Kim SY; Lee JH; Lee S; Oh SY; Han JY; Kim HJ; Kim SH Korean J Intern Med; 2015 Nov; 30(6):884-90. PubMed ID: 26552464 [TBL] [Abstract][Full Text] [Related]
14. The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis. Bai Y; Shi M; Yang X; Zhang W; Yang R; Wei X; Wei X; Duan L; Wang C; Mi R; Waqas Ahmed HA; Huo L; Chen Y; Xu F; Wu D; Sun K Leuk Res; 2019 Apr; 79():34-37. PubMed ID: 30831481 [TBL] [Abstract][Full Text] [Related]
15. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Rodríguez Gómez M; López Fernández MF; Batlle J Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380 [TBL] [Abstract][Full Text] [Related]
16. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases]. Murakoshi T Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368 [TBL] [Abstract][Full Text] [Related]
17. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia. Tallman MS; Abutalib SA; Altman JK Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890 [TBL] [Abstract][Full Text] [Related]
18. Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institution. Matsuo K; Kiura K; Tabata M; Uchida A; Hotta K; Niiya D; Kubonishi S; Ogino A; Fujiwara Y; Nakajima H; Shinagawa K; Ishimaru F; Ueoka H; Tanimoto M Am J Hematol; 2006 May; 81(5):349-54. PubMed ID: 16628731 [TBL] [Abstract][Full Text] [Related]
19. Occlusion of the carotid artery as presenting symptom of acute promyelocytic leukemia. Delodovici M; Chelazzi G; Dario A; Castelli F; Crivelli G; Dorizzi A Schweiz Arch Neurol Psychiatr (1985); 1991; 142(4):307-11. PubMed ID: 1719625 [TBL] [Abstract][Full Text] [Related]